Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041187 | SCV000064878 | benign | not specified | 2015-04-08 | criteria provided, single submitter | clinical testing | p.Glu332Ala in exon 9 of NEXN: This variant is not expected to have clinical sig nificance because it has been identified in 1.3% (207/16506) of South Asian chro mosomes, including 4 homozygotes, by the Exome Aggregation Consortium (ExAC, htt p://exac.broadinstitute.org; dbSNP rs201763096). |
Gene |
RCV000041187 | SCV000236123 | benign | not specified | 2016-11-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000231450 | SCV000291374 | benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000041187 | SCV000339207 | benign | not specified | 2016-02-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528784 | SCV000604454 | benign | not provided | 2023-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618713 | SCV000735346 | benign | Cardiovascular phenotype | 2016-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769821 | SCV000901247 | benign | Cardiomyopathy | 2019-05-22 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV001781365 | SCV000995287 | benign | Premature ventricular contraction | 2019-03-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000231450 | SCV002799091 | benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528784 | SCV004009856 | benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | NEXN: BP4, BS1, BS2 |
Stanford Center for Inherited Cardiovascular Disease, |
RCV000041187 | SCV000280402 | uncertain significance | not specified | 2013-08-01 | no assertion criteria provided | clinical testing | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Glu332Ala (c.995 A>C) in the NEXN gene. This variant is reviewed in detail below. Recently, missense mutations that cause defective interaction between nexilin and alpha-actin have been described in HCM. Nexilin (NEXN) is a cardiac Z-disc protein that has a crucial function to protect cardiac Z-discs from forces generated within the sarcomere. The Z-disc complex is located at either end of the contractile unit of the striated muscle and links titin and actin filaments from opposing sarcomere halves in a lattice connected by ?-actinin. The Z-discs provide a backbone for the insertions of actin-based thin filaments and represent a key interface between the contractile apparatus and the cytoskeleton. In addition, the complex molecular network of Z-disc proteins is pivotal for reception, transduction, and transmission of mechanical and biochemical signals Hassel et al. (2009) found that nexilin is highly abundant in the heart and skeletal muscle and is located specifically to the Z-disc; loss of nexilin in zebrafish led to perturbed Z-disc stability and heart failure. They identified one deletion and two missense mutations in NEXN in a large cohort of patients with dilated cardiomyopathy. Wang et al. (2010) Reported variants in NEXN to cause HCM. They screened NEXN in 121 unrelated HCM patients who did not carry any mutation in eight genes commonly mutated in myofilament disease and identified two missense variants. The variant p. Glu332Ala has not been published in the literature. In silico analysis with PolyPhen-2 predicts the variant to be is benign. Analysis with Mutation Taster predicts it to be disease causing with a score of 2.92. The 332 at codon is conserved across species, as are neighboring amino acids. Other variants have been reported in association with disease at nearby codons. Gu332Ala results in a non-conservative amino acid substitution of a negtatively-charged Glutamic acid residue with a non-polar Alanine residue at a positive that is class conserved across species. In total the variant has been seen in 24/11896 published controls and individuals from publicly available population datasets. GeneDx did not provide laboratory control data. The NHLBI Exome Sequencing Project dataset identified this variant in 20/8186 alleles from individuals of European ancestry and 4/3710 alleles from individual of African American ancestry, which currently includes variant calls on ~6000 Caucasian and African American individuals (as of 5/15/13). There is no variation at this codon listed in dbSNP or 1000 genomes (as of 5/15/13). |
Diagnostic Laboratory, |
RCV001528784 | SCV001741133 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041187 | SCV001923524 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041187 | SCV001931161 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041187 | SCV001959782 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528784 | SCV001973152 | likely benign | not provided | no assertion criteria provided | clinical testing |